Versant Venture Capital VI, L.P. - 10%+ Owner at Black Diamond Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
BDTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Versant Venture Capital VI, L.P. since 11/21/2024

Holdings reported by Versant Venture Capital VI, L.P. for Black Diamond Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.73M $23.6M $6.32 Aug 28, 2024 Direct
Common Stock 822K $5.2M $6.32 Aug 28, 2024 Indirect

Transactions reported by Versant Venture Capital VI, L.P. for Black Diamond Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.